1. A Pilot Study Showing Acute Inhibitory Effect of GLP‐1 on the Bone Resorption Marker CTX in Humans. (23rd August 2019) Authors: Nissen, Anne; Marstrand, Simone; Skov‐Jeppesen, Kirsa; Bremholm, Lasse; Hornum, Mads; Andersen, Ulrik B; Holst, Jens Juul; Rosenkilde, Mette Marie; Hartmann, Bolette Journal: JBMR plus Issue: Volume 3:Number 10(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Capillary transit time heterogeneity inhibits cerebral oxygen metabolism in patients with reduced cerebrovascular reserve capacity from steno-occlusive disease. Issue 3 (March 2023) Authors: Vestergaard, Mark B; Iversen, Helle K; Simonsen, Sofie Amalie; Lindberg, Ulrich; Cramer, Stig P; Andersen, Ulrik B; Larsson, Henrik BW Journal: Journal of cerebral blood flow & metabolism Issue: Volume 43:Issue 3(2023) Page Start: 460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of increased potassium intake on the renin–angiotensin–aldosterone system and subcutaneous resistance arteries: a randomized crossover study. Issue 6 (6th December 2020) Authors: Dreier, Rasmus; Abdolalizadeh, Bahareh; Asferg, Camilla L; Hölmich, Lisbet R; Buus, Niels H; Forman, Julie L; Andersen, Ulrik B; Egfjord, Martin; Sheykhzade, Majid; Jeppesen, Jørgen L Journal: Nephrology dialysis transplantation Issue: Volume 36:Issue 6(2021) Page Start: 1139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of increased potassium intake on the renin–angiotensin–aldosterone system and subcutaneous resistance arteries: a randomized crossover study. Issue 7 (29th June 2020) Authors: Dreier, Rasmus; Abdolalizadeh, Bahareh; Asferg, Camilla L; Hölmich, Lisbet R; Buus, Niels H; Forman, Julie L; Andersen, Ulrik B; Egfjord, Martin; Sheykhzade, Majid; Jeppesen, Jørgen L Journal: Nephrology dialysis transplantation Issue: Volume 36:Issue 7(2021) Page Start: 1282 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Epicardial, pericardial and total cardiac fat and cardiovascular disease in type 2 diabetic patients with elevated urinary albumin excretion rate. (29th August 2020) Authors: Christensen, Regitse H; von Scholten, Bernt J; Hansen, Christian S; Heywood, Sarah E; Rosenmeier, Jaya B; Andersen, Ulrik B; Hovind, Peter; Reinhard, Henrik; Parving, Hans-Henrik; Pedersen, Bente K; Jørgensen, Marit E; Jacobsen, Peter K; Rossing, Peter Journal: European journal of preventive cardiology Issue: Volume 24:Number 14(2017) Page Start: 1517 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Epicardial, pericardial and total cardiac fat and cardiovascular disease in type 2 diabetic patients with elevated urinary albumin excretion rate. (September 2017) Authors: Christensen, Regitse H; von Scholten, Bernt J; Hansen, Christian S; Heywood, Sarah E; Rosenmeier, Jaya B; Andersen, Ulrik B; Hovind, Peter; Reinhard, Henrik; Parving, Hans-Henrik; Pedersen, Bente K; Jørgensen, Marit E; Jacobsen, Peter K; Rossing, Peter Journal: European journal of preventive cardiology Issue: Volume 24:Number 14(2017) Page Start: 1517 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. O12.4. EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST EXENATIDE ON BONE STATUS IN OBESE, NON-DIABETIC, ANTIPSYCHOTIC-TREATED SCHIZOPHRENIA SPECTRUM PATIENTS. (9th April 2019) Authors: Eriksson, Robert; Broberg, Brian V; Ishoy, Pelle Lau; Bak, Nikolaj; Andersen, Ulrik B; Jørgensen, Niklas R; Knop, Filip K; Ebdrup, Bjorn Journal: Schizophrenia bulletin Issue: Volume 45(2019)Supplement 2 Page Start: S198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Serum proatrial natriuretic peptide does not increase with higher systolic blood pressure in obese men. Issue 2 (5th August 2016) Authors: Asferg, Camilla L; Andersen, Ulrik B; Linneberg, Allan; Hedley, Paula L; Christiansen, Michael; Goetze, Jens P; Jeppesen, Jørgen L Journal: Heart Issue: Volume 103:Issue 2(2017) Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist—protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol. Issue 1 (8th January 2014) Authors: Ishøy, Pelle L; Knop, Filip K; Broberg, Brian V; Baandrup, Lone; Fagerlund, Birgitte; Jørgensen, Niklas R; Andersen, Ulrik B; Rostrup, Egill; Glenthøj, Birte Y; Ebdrup, Bjørn H Journal: BMJ open Issue: Volume 4:Issue 1(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗